Patent details

EP3762015 Title: GUSELKUMAB FOR USE IN THE TREATMENT OF CROHN'S DISEASE WITH A DOSAGE REGIMEN

Basic Information

Publication number:
EP3762015
PCT Application Number:
IB2019051732
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197648561
PCT Publication Number:
WO2019171252
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GUSELKUMAB FOR USE IN THE TREATMENT OF CROHN'S DISEASE WITH A DOSAGE REGIMEN
French Title of Invention:
GUSELKUMAB POUR L'UTILISATION DANS LE TRAITEMENT DE LA MALADIE DE CROHN AVEC UN PLAN DE DOSAGE
German Title of Invention:
GUSELKUMAB ZUR VERWENDUNG IN DER BEHANDLUNG VON MORBUS CROHN MIT EINEM DOSIERUNGSPLAN
SPC Number:

Dates

Filing date:
04/03/2019
Grant date:
24/12/2025
EP Publication Date:
13/01/2021
PCT Publication Date:
12/09/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/12/2025
EP B1 Publication Date:
24/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/03/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/12/2025
 
 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Agent

Name:
NOVAGRAAF BREVETS
From:
06/02/2026
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
CHAN, Daphne
Address:
United States (US)

2

Name:
CHEN, Yang
Address:
United States (US)

3

Name:
SZAPARY, Philippe
Address:
United States (US)

4

Name:
ADEDOKUN, Omoniyi
Address:
United States (US)

Priority

Priority Number:
201862638624 P
Priority Date:
05/03/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/17; A61K 39/395; A61P 1/00; C07K 14/54; C07K 16/24;

Publication

European Patent Bulletin

1

Issue number:
202552
Publication date:
24/12/2025
Description:
Grant (B1)

2

Issue number:
202605
Publication date:
28/01/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2026
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
06/02/2026 Power Of Attorney 1
09/02/2026 Outgoing Correspondence 1